Orion Oyj Berita Eulerpool

Orion Oyj Eulerpool News

Orion Oyj Berita Saham

Orion Oyj diawasi oleh banyak jurnalis dan investor di seluruh dunia. Berita terkini Orion Oyj kami rangkum di sini.

• 26 September ·

  Yahoo
  Orion OYJ (ORINY) Is a Great Choice for 'Trend' Investors, Here's Why
• 26 September ·

  Yahoo
  Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster
• 26 September ·

  GlobeNewswire
  Orion?s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster
• 25 September ·

  Yahoo
  Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology
• 20 September ·

  Yahoo
  213,285 Orion Corporation A shares converted into B shares
• 16 September ·

  Yahoo
  Darolutamide plus androgen deprivation therapy significantly reduced the risk of radiological progression or death by 46% compared to placebo plus ADT in patients with metastatic hormone-sensitive prostate cancer
• 11 September ·

  Yahoo
  Inside information: Orion upgrades full-year outlook for 2024
• 2 September ·

  Yahoo
  3 Reasons Why Growth Investors Shouldn't Overlook Orion OYJ (ORINY)
• 22 Agustus ·

  Yahoo
  Orion Corporation: Managers’ transactions – Satu Ahomäki
• 21 Agustus ·

  Yahoo
  Orion Corporation: Managers’ transactions – Niclas Lindstedt